Diabetes mellitus is one of the major health problems in the world, the incidence and associated mortality are increasing. Inadequate regulation of the blood sugar imposes serious consequences for health. Conventional antidiabetic drugs are effective, however, also with unavoidable side effects. On the other hand, medicinal plants may act as an alternative source of antidiabetic agents.
1. Introduction
Diabetes mellitus (DM) is a serious, chronic, and complex metabolic disorder of multiple aetiologies with profound consequences, both acute and chronic
[1]. Also known only as diabetes, DM and its complications affect people both in the developing and developed countries, leading to a major socioeconomic challenge. It is estimated that 25% of the world population is affected by this disease
[2]. Genetic and environmental factors contribute significantly to the development of diabetes
[3]. During the development of diabetes, the cells of the body cannot metabolize sugar properly due to deficient action of insulin on target tissues resulting from insensitivity or lack of insulin (a peptide hormone that regulates blood glucose). The inability of insulin to metabolize sugar occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. This triggers the body to break down its own fat, protein, and glycogen to produce sugar, leading to the presence of high sugar levels in the blood with excess by-products called ketones being produced by the liver
[4][5]. Diabetes is distinguished by chronic hyperglycemia with disturbances in the macromolecules’ metabolism as a result of impairments in insulin secretion, insulin action, or both. Diabetes causes long-term damage, dysfunction, and failure of various organ systems (heart, blood vessels, eyes, kidneys, and nerves), leading to disability and premature death
[6]. The severity of damage triggered by hyperglycemia on the respective organ systems may be related to how long the disease has been present and how well it has been controlled. Several symptoms such as thirst, polyuria, blurring of vision, and weight loss also accompany diabetes
[7].
2. Medicinal Plants as an Alternative Source of Antidiabetic Agents
Natural products, particularly of plant origin, are the main quarry for discovering promising lead candidates and play an imperative role in the upcoming drug development programs
[8][9][10]. Ease of availability, low cost, and least side effects make plant-based preparations the main key player of all available therapies, especially in rural areas
[11]. Moreover, many plants provide a rich source of bioactive chemicals, which are free from undesirable side effects and possess powerful pharmacological actions
[12][13][14][15][16][17][18]. Plants also have always been an exemplary source of drugs with many of the currently available drugs being obtained directly or indirectly from them
[2][13][14][15]. The recent review of Durazzo et al.
[19] gives a current snapshot of the strict interaction between the main biologically active compounds in plants and botanicals by giving a mini overview of botanicals features, a definition of the study, and examples of innovative (i.e., an assessment of the interaction of bioactive compounds, chemometrics, and the new goal of biorefineries) and a description of existing databases (i.e., plant metabolic pathways, food composition, bioactive compounds, dietary supplements, and dietary markers); in this regard, the authors marked the need for categorization of botanicals as useful tools for health research
[19].
For centuries, many plants have been considered a fundamental source of potent antidiabetic drugs. In developing countries, particularly, medicinal plants are used to treat diabetes to overcome the burden of the cost of conventional medicines to the population
[2]. Nowadays, treatments of diseases including diabetes using medicinal plants are recommended
[20] because these plants contain various phytoconstituents such as flavonoids, terpenoids, saponins, carotenoids, alkaloids, and glycosides, which may possess antidiabetic activities
[21]. Also marked by Durazzo et al.
[19], the combined action of biologically active compounds (i.e., polyphenols, carotenoids, lignans, coumarins, glucosinolates, etc.) leads to the potential beneficial properties of each plant matrix, and this can represent the first step for understanding their biological actions and beneficial activities. Generally, the main current approaches of study
[22][23] of the interactions of phytochemicals can be classified: (i) model system development of interactions
[24][25][26]; (ii) study of extractable and nonextractablecompounds
[27][28]; or (iii) characterization of biologically active compound-rich extracts
[29][30].
The antihyperglycemic effects resulting from treatment with plants are usually attributed to their ability to improve the performance of pancreatic tissue, which is done by increasing insulin secretions or by reducing the intestinal absorption of glucose
[2].
The number of people with diabetes today has been growing and causing increasing concerns in the medical community and the public. Despite the presence of antidiabetic drugs in the pharmaceutical market, the treatment of diabetes with medicinal plants is often successful. Herbal medicines and plant components with insignificant toxicity and no side effects are notable therapeutic options for the treatment of diabetes around the world
[31]. Most tests have demonstrated the benefits of medicinal plants containing hypoglycemic properties in diabetes management. Ríos et al.
[32] described medicinal plants (i.e., aloe, banaba, bitter melon, caper, cinnamon, cocoa, coffee, fenugreek, garlic, guava, gymnema, nettle, sage, soybean, green and black tea, turmeric, walnut, and yerba mate) used for treating diabetes and its comorbidities and the mechanisms of natural products as antidiabetic agents, with attention to compounds of high interest such as fukugetin, palmatine, berberine, honokiol, amorfrutins, trigonelline, gymnemic acids, gurmarin, and phlorizin. The current review of Bindu and Narendhirakannan
[33] has categorized and described from literature 81 plants native to Asian countries with antidiabetic, antihyperglycemic, hypoglycemic, anti-lipidemic, and insulin-mimetic properties.
In the
Artemisia genus,
Artemisia absinthium is one of the traditional medicinal plant used for diabetes treatment
[34].
Artemisia afra is one of the popular herbal medicines used in the southern part of Africa
[35].
Artemisia herba-alba is a traditional medicinal plant
[36], and its aqueous extract of the leaves and barks reduces blood glucose levels
[37].
Solanum americanum is a traditional medicine used in Guatemala
[38], while
Solanum viarum is used in India
[39].
Terminalia arjuna is a plant used in India and Bangladesh
[40] and exhibits amylase inhibition (IC
50 value of 302 μg/mL)
[41].
Terminalia chebula is a medicinal plant used in India
[42], Bangladesh
[43], Thailand
[44], and Iran
[45].
Euphorbia ligularia [46],
Euphorbia neriifolia [47], and
Euphorbia caducifolia [48] are some of the plants traditionally used in India. Similarly,
Euphorbia thymifolia and
Euphorbia hirta are used in Bangladesh
[49][50], and
Euphorbia kansui is a Korean traditional medicinal plant used for diabetes treatment
[51].
Allium cepa,
Mangifera indica,
Murraya koenigii, and
Phyllanthus amarus reduce triglycerides (TG), total cholesterol (TC), and very low-density lipoproteins (VLDL) levels and exhibit antidiabetic and hypolipidemic effects
[52].
3. Medicinal Plants with Antidiabetic Potential
3.1. Preclinical In Vitro/In Vivo (Animal) Studies
Several plant species having hypoglycemic activity have been available in the literature; most of these plants contain bioactive compounds such glycosides, alkaloids, terpenoids, flavonoids, carotenoids, etc., that are frequently implicated as having an antidiabetic effect. In this section, plant species with antidiabetic potential will be organized in alphabetical order (
Table 13).
Table 13. Plant extracts with antidiabetic potential.
Species |
Extract |
Part of the Plant |
Dosage (mg/kg) |
Experimental Model |
Induction of Diabetes |
Reference |
Acacia arabica |
chloroform |
bark |
250, 500 |
male Wistar rats and albino mice |
alloxan |
[53] |
chloroform |
bark |
100, 200 |
female albino rats |
streptozotocin |
[54] |
Achyranthes rubrofusca |
aqueous and ethanolic |
leaves |
200 |
rats |
alloxan |
[55] |
Albizzia lebbeck |
methanol/dichloro-methane |
stem bark |
100, 200, 300, 400 |
male albino Wistar rats |
streptozotocin |
[56] |
methanolic |
bark |
200, 350, 620 |
female Sprague–Dawley rats |
streptozotocin-nicotinamide |
[57] |
Aloe vera |
aqueous |
leaves |
130 |
swiss albino mice |
streptozotocin |
[58] |
ethanolic |
leaves |
300 |
male albino Wistar rats |
streptozotocin |
[59] |
Amaranthus tricolor |
methanolic |
whole plant |
50, 100, 200, 400 |
male swiss albino mice |
glucose-induced hyperglycemia |
[60] |
Anacardium occidentale |
aqueous |
leaves |
175 |
male albino Wistar rats |
streptozotocin |
[61] |
methanolic |
leaves |
100 |
female albino mice |
streptozotocin |
[62] |
Azadirachta indica |
ethanolic |
leaves |
200 |
adult rabbits |
alloxan |
[63] |
Barleria prionitis |
ethanolic |
leaves and root |
200 |
adult albino rats |
alloxan |
[64] |
Bauhinia thoningii |
aqueous |
leaves |
500 |
Wistar albino rats |
alloxan |
[65] |
Caesalpinia ferrea |
aqueous |
stem bark |
300, 450 |
male Wistar rats |
streptozotocin |
[66] |
Camellia sinensis |
crude tea |
leaves |
0.5 mL/day |
male albino mice |
streptozotocin |
[67] |
Casearia esculenta Roxb |
aqueous |
root |
200, 300 |
male albino Wistar rats |
streptozotocin |
[68] |
Cassia fistula |
ethanolic |
stem bark |
250, 500 |
Wistar rats |
alloxan |
[69] |
Cassia grandis |
aqueous and ethanolic |
stem |
150 |
male albino Wistar rats |
alloxan |
[70] |
Catharanthus roseus |
dichloromethane-methanol |
leaves and twigs |
500 |
male Sprague–Dawley rats |
streptozotocin |
[71] |
ethanolic |
leaves |
100, 200 |
male Wistar rats |
streptozotocin |
[72] |
Cecropia pachystachya |
methanolic |
leaves |
80 |
male Wistar rats |
alloxan |
[73] |
Ceriops decandra |
ethanolic |
leaves |
30, 60, 120 |
male albino Wistar rats |
alloxan |
[74] |
Chiliadenus iphionoides |
ethanolic |
aerial parts |
1000 |
male and female diabetes-prone Psammomys obesus |
- |
[75] |
Cinnamomum cassia |
ethanolic |
bark |
200, 300 |
male Kunming mice |
streptozotocin |
[76] |
Cinnamomum japonica |
ethanolic |
bark |
200, 300 |
male Kunming mice |
streptozotocin |
[76] |
Citrullus colocynthis |
aqueous |
root |
2000 |
male and female Wistar rats and Swiss albino mice |
alloxan |
[77] |
aqueous |
seed |
1, 2 mL/kg |
male Wistar albino rats |
alloxan |
[78] |
Coscinium fenestratum |
ethanolic |
stem |
250 |
male albino Wistar rats |
streptozotocin-nicotinamide |
[79] |
Eucalyptus citriodora |
aqueous |
leaves |
250, 500 |
albino rats |
alloxan |
[80] |
Gymnema sylvestre |
ethanolic |
leaves |
100 |
male Sprague–Dawley rats |
streptozotocin |
[81] |
Heinsia crinata |
ethanolic |
leaves |
450–1350 |
rats |
alloxan |
[82] |
Helicteres isora |
butanol and aqueous ethanol |
roots |
250 |
male Wistar rats |
alloxan |
[83] |
Momordica charantia |
aqueous |
pulp |
13.33 g pulp/kg |
male albino Wistar rats |
alloxan |
[84] |
ethanolic |
fruit |
200 |
adult rabbits |
alloxan |
[63] |
ethanolic |
fruit |
400 |
male Sprague–Dawley rats |
streptozotocin |
[85] |
Moringa oleifera |
methanolic |
pod |
150, 300 |
Wistar albino rats |
streptozotocin |
[86] |
- |
leaves |
50 |
male Sprague–Dawley rats |
alloxan |
[87] |
Murraya koenigii |
aqueous |
leaves |
200, 300, 400 |
male albino rabbits |
alloxan |
[88] |
ethanolic |
leaves |
100, 250 |
male albino Swiss mice |
dexamethasone |
[89] |
Opuntia ficus-indica |
petroleum ether |
stems |
200 |
male ICR mice |
streptozotocin |
[90] |
Origanum vulgare |
methanolic |
leaves |
5 |
male C57BL/6 mice |
streptozotocin |
[91] |
Passiflora nitida |
hydro-ethanolic |
leaves |
50 |
female Wistar rats |
streptozotocin |
[92] |
Paspalum scrobiculatum |
aqueous and ethanolic |
grains |
250, 500 |
male Wistar albino rats |
alloxan |
[93] |
Persea americana |
hydro-alcoholic |
leaves |
150, 300 |
male Wistar rats |
streptozotocin |
[94] |
aqueous |
seed |
20, 30, 40 g/L |
male Wistar albino rats |
alloxan |
[95] |
Phoenix dactylifera |
ethanolic |
leaves |
50-400 |
male Wistar rats |
alloxan |
[96] |
Phyllanthus niruri |
aqueous |
leaves |
200, 400 |
male Wistar rats |
streptozotocin-nicotinamide |
[97] |
Phyllanthus simplex |
petroleum ether, ethyl acetate, methanol and water fraction |
|
100–400 |
rats |
alloxan |
[98] |
Picralima nitida |
methanolic |
steam bark and leaves |
75, 150, 300 |
Wistar rats |
streptozotocin |
[99] |
Piper longum |
aqueous |
root |
200, 300, 400 |
male Wistar albino rats |
streptozotocin |
[100] |
Sonchus oleraceus |
hydro-alcoholic |
whole plant |
75, 150, 300 |
Wistar rats |
streptozotocin |
[99] |
Syzygium jambolana |
ethanolic |
seed |
200 |
adult rabbits |
alloxan |
[63] |
Tamarindus indica |
ethanolic |
stem bark |
250, 500 |
Wistar rats |
alloxan |
[69] |
ethanolic |
seed coat |
500 |
Wistar albino rats |
alloxan |
[101] |
Terminalia chebula |
chloroform |
seed |
100, 200, 300 |
male Sprague–Dawley rats |
streptozotin |
[102] |
Terminalia catappa |
petroleum ether, methanol and aqueous |
fruit |
68, 40, 42 |
Wistar albino rats and mice |
alloxan |
[103] |
Trigonella foenum-graecum |
ethanolic |
seed |
100, 500, 1000, 2000 |
male Wistar albino rats |
alloxan |
[104] |
hydro-alcoholic |
seed |
500, 1000, 2000 |
Sprague–Dawley rats |
alloxan |
[105] |
Vaccinium arctostaphylos |
ethanolic |
fruit |
200, 400 |
male Wistar rats |
alloxan |
[106] |
Vernonia amygdalina |
aqueous |
leaves |
100 |
Wistar albino rats |
alloxan |
[107] |
Witheringia solanacea |
aqueous |
leaves |
500, 1000 |
male Sprague–Dawley rats |
GTT |
[108] |
Zaleya decandra |
ethanolic |
roots |
200 |
Wistar albino rats |
alloxan |
[109] |
Zizyphus mauritiana |
petroleum ether, chloroform, acetone, ethanol and aqueous |
fruit |
200, 400 |
female Wistar rats |
alloxan |
[110] |